West Pharmaceutical Services (WST) Scheduled to Post Quarterly Earnings on Thursday

West Pharmaceutical Services (NYSE:WST) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, October 24th. Analysts expect West Pharmaceutical Services to post earnings of $1.51 per share for the quarter. West Pharmaceutical Services has set its FY 2024 guidance at 6.350-6.650 EPS.Individual interested in listening to the company’s earnings conference call can do so using this link.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.22). West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The company had revenue of $702.10 million during the quarter, compared to the consensus estimate of $729.36 million. During the same period in the previous year, the business posted $2.11 earnings per share. The firm’s revenue was down 6.9% on a year-over-year basis. On average, analysts expect West Pharmaceutical Services to post $6 EPS for the current fiscal year and $8 EPS for the next fiscal year.

West Pharmaceutical Services Stock Down 0.3 %

Shares of WST stock opened at $286.40 on Wednesday. The stock’s 50 day simple moving average is $299.90 and its 200 day simple moving average is $323.82. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.68 and a current ratio of 2.34. West Pharmaceutical Services has a twelve month low of $265.00 and a twelve month high of $413.70. The company has a market capitalization of $20.86 billion, a price-to-earnings ratio of 37.78, a PEG ratio of 10.46 and a beta of 1.01.

Insider Activity at West Pharmaceutical Services

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 1,029 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $300.00, for a total value of $308,700.00. Following the sale, the vice president now owns 1,478 shares of the company’s stock, valued at $443,400. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.53% of the stock is owned by company insiders.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.